Abstract:BACKGROUND:This study was designed to obtain a recombinant retroviral vector containing the human hepatocellular carcinoma-related gene ANGPTL4 (angiopoietin-like 4) cDNA and to evaluate the anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.METHODS:ANGPTL4 cDNA was cloned in vitro from normal human liver cells HL-7702 by using RT-PCR, and then subcloned into the plasmid vector pMSCV and sequenced. The retroviral plasmid vectors pMSCV-ANGPTL4, pVSV, and pGAG-POL were co-transfected into the packaging cell line 293 EBNA under mediation of lipofectamine. A high-titer retrovirus was obtained as a result, and HepG2 cells were infected with this retrovirus in vitro. Flow cytometry and fluorescence microscopy were used to detect expression of green fluorescence protein (GFP). The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was investigated using RT-PCR. The formation of tumors in nude mice and MTT assays were used to detect the growth of HepG2-ANGPTL4 cells in vivo and in vitro, respectively.RESULTS:The cDNA sequence of the cloned ANGPTL4 gene was consistent with the recently reported sequence. Thus, the recombinant retroviral vector pMSCV-ANGPTL4 was constructed successfully. The titer of the packaged recombinant retrovirus was 1.4 x 10(6) infective viral grains/ml, and the rate of HepG2-ANGPTL4 cells expressing GFP was 68.45%, with an average intensity of fluorescence 31.67 times greater in HepG2-ANGPTL4 cells than in HepG2 cells. The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was higher than in HepG2-pMSCV cells (154% higher) or HepG2 cells (161% higher). The proliferation rate of HepG2-ANGPTL4 cells in vitro was obviously lower than those of HepG2-pMSCV cells and HepG2 cells (P <0.01). The mean volume and weight of tumors seeded from HepG2-ANGPTL4 cells were obviously lower than the mean volume or weight of tumors seeded from HepG2 cells and HepG2-pMSCV cells (P <0.01).CONCLUSION:A stable ANGPTL4-transfected human liver cancer cell line HepG2-ANGPTL4 has been created. The transfer of the human ANGPTL4 gene mediated by a retroviral vector is a possibly effective approach for liver cancer therapy.

Anti-angiogenesis Effectiveness of Recombinant Plasmid Paav-Tip30 Transfected by Polylactic-Co-glycolic Acid Nanoparticles in Vitro

Anti-tumor Effect of Recombinant Retroviral Vector-Mediated Human ANGPTL4 Gene Transfection.

Tip30 Inhibits Growth Of Hcc Cell Lines And Inhibits Hcc Xenografts In Mice In Combination With 5-Fu

Construction of TIP30 expression vector and its expression in HepG2 cells

Construction of adenovirus vector expressing TIP30 and its tumor suppressive effect in vitro and in vivo

Effects of miR-30 c on viability and migratory ability of HUVECs by tar-geting PAI-1

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

Effect of TSP1f Gene Transfer on Proliferation of Human Umbilical Vein Endothelial Cells ECV304

Efficacy of Dendrimer-Mediated Angiostatin and Timp-2 Gene Delivery on Inhibition of Tumor Growth and Angiogenesis: in Vitro and in Vivo Studies

[Effects of Platelet Derived Growth Factor Antisense Oligodeoxynucleotides and Tissue-Type Plasminogen Activator Gene Transfection on Inhibition of Intimal Proliferation].

Inhibitory effect of TIP30 gene on growth of human renal carcinoma786-0 cells

Inhibitory Effects of Tip30 Combined with Paclitaxel on Salivary Gland Adenoid Cystic Carcinoma Cells

Effect of recombinant plasmid pEGFP-AFP-hTNF on liver cancer cells (HepG2 Cells) in vitro when delivered by PEG-PEI/Fe₃O₄ nanomagnetic fluid

TIP30 Acts As a Tumor Suppressor in Hepatocarcinogenesis

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

Tip30 Deficiency Increases Susceptibility To Tumorigenesis

TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin

Recombinant Expression and Purification of a MAP30-cell Penetrating Peptide Fusion Protein with Higher Anti-Tumor Bioactivity.

Effects of recombinant adenovirus-mediated overexpression of TIMP-1 on invasion of human liver carcinoma cell line in vitro

Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Hindlimb of Ischemia

Effects of ANGPTL3 Antisense Oligodeoxynucleotides Transfection on the Cell Growths and Invasion of Human Hepatocellular Carcinoma Cells.